Ketamine Infusions Disappoint in New Depression Trial

A new clinical trial published in **JAMA Psychiatry** has found that repeated **ketamine** infusions offer no meaningful advantage over an active **placebo** for patients with **depression**. The **KARMA-Dep 2** study, conducted at **Trinity College Dublin**'s St. Patrick's University Hospital, compared **ketamine** to **midazolam**, a sedative that mimics **ketamine**'s psychoactive effects. Both groups saw mood improvements, but adjusted analyses failed to show a clinically meaningful difference. The study's findings suggest that **ketamine**'s antidepressant reputation might be overstated. This trial is significant because it reflects real-world clinical practice, where patients often receive multiple treatments simultaneously. For more information on **depression** and its treatment, see [[depression|Depression]]. The use of **ketamine** in treating **depression** is also discussed in [[ketamine-and-suicidal-thoughts|Ketamine and Suicidal Thoughts]]. The implications of this study are far-reaching, as **ketamine** has been hailed as a potential breakthrough treatment for **depression**. However, the results of this trial suggest that **ketamine** may not be as effective as previously thought. The study's authors, including **Declan McLoughlin**, PhD, of **Trinity College Dublin**, conclude that **ketamine**'s antidepressant efficacy may have been overstated. For more information on the latest research and developments in **psychiatry**, see [[psychiatrist|Psychiatrist]]. The study's findings also highlight the importance of rigorous clinical trials in evaluating the effectiveness of new treatments, as discussed in [[clinical-trials|Clinical Trials]].

• The **KARMA-Dep 2** study found that repeated **ketamine** infusions offered no meaningful advantage over an active **placebo** for patients with **depression**
• The study's findings suggest that **ketamine** may not be as effective as previously thought
• The study's results highlight the importance of rigorous clinical trials in evaluating the effectiveness of new treatments
• The use of **ketamine** as a treatment for **depression** may be associated with significant risks and side effects
• More research is needed to fully understand the effects of **ketamine** treatment for **depression**

The results of this trial provide a nuanced view of **ketamine**'s potential as a treatment for **depression**. While **ketamine** did not outperform the **placebo**, it was still associated with measurable mood improvements. The study's findings suggest that **ketamine** may be a useful adjunctive treatment for certain patients, but more research is needed to fully understand its effects. For more information on the latest research and developments in **psychiatry**, see [[psychiatry-research|Psychiatry Research]]. The study's findings also highlight the importance of individualized treatment plans, as discussed in [[personalized-medicine|Personalized Medicine]].

While the results of this trial may be disappointing, they do not necessarily mean that **ketamine** has no potential as a treatment for **depression**. The study's authors note that **ketamine** was generally safe and well-tolerated, and that it may still have a role to play in treating certain patients. Additionally, the study's findings highlight the importance of continued research into new and innovative treatments for **depression**, such as **ketamine**. For more information on the potential benefits and risks of **ketamine** treatment, see [[ketamine-treatment|Ketamine Treatment]]. The use of **ketamine** in treating **depression** is also discussed in [[depression-treatment|Depression Treatment]].

The results of this trial are a significant setback for **ketamine**'s reputation as a miracle cure for **depression**. The study's findings suggest that **ketamine** may not be as effective as previously thought, and that its use may be associated with significant risks and side effects. The study's authors conclude that **ketamine**'s antidepressant efficacy may have been overstated, and that more research is needed to fully understand its effects. For more information on the potential risks and side effects of **ketamine** treatment, see [[ketamine-risks|Ketamine Risks]]. The use of **ketamine** in treating **depression** is also discussed in [[depression-risks|Depression Risks]].

Originally reported by Psychiatrist.com